annual cash & cash equivalents:
$333.73M+$76.50M(+29.74%)Summary
- As of today (July 6, 2025), PRCT annual cash & cash equivalents is $333.73 million, with the most recent change of +$76.50 million (+29.74%) on December 31, 2024.
- During the last 3 years, PRCT annual cash & cash equivalents has risen by +$29.41 million (+9.66%).
- PRCT annual cash & cash equivalents is now at all-time high.
Performance
PRCT Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$316.21M-$17.52M(-5.25%)Summary
- As of today (July 6, 2025), PRCT quarterly cash & cash equivalents is $316.21 million, with the most recent change of -$17.52 million (-5.25%) on March 1, 2025.
- Over the past year, PRCT quarterly cash & cash equivalents has increased by +$90.63 million (+40.18%).
- PRCT quarterly cash & cash equivalents is now -5.25% below its all-time high of $333.73 million, reached on December 31, 2024.
Performance
PRCT quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
PRCT Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +29.7% | +40.2% |
| 3 y3 years | +9.7% | +11.2% |
| 5 y5 years | +694.2% | - |
PRCT Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +50.4% | -5.3% | +111.2% |
| 5 y | 5-year | at high | +694.2% | -5.3% | +215.8% |
| alltime | all time | at high | +694.2% | -5.3% | +215.8% |
PRCT Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $316.21M(-5.2%) |
| Dec 2024 | $333.73M(+29.7%) | $333.73M(+69.6%) |
| Sep 2024 | - | $196.76M(-8.1%) |
| Jun 2024 | - | $214.09M(-5.1%) |
| Mar 2024 | - | $225.58M(-12.3%) |
| Dec 2023 | $257.22M(+15.9%) | $257.22M(-10.4%) |
| Sep 2023 | - | $287.09M(+91.8%) |
| Jun 2023 | - | $149.69M(-17.3%) |
| Mar 2023 | - | $180.97M(-18.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $221.86M(-27.1%) | $221.86M(-11.0%) |
| Sep 2022 | - | $249.22M(-7.6%) |
| Jun 2022 | - | $269.81M(-5.1%) |
| Mar 2022 | - | $284.29M(-6.6%) |
| Dec 2021 | $304.32M(+203.9%) | $304.32M(-5.0%) |
| Sep 2021 | - | $320.48M(+101.3%) |
| Jun 2021 | - | $159.22M(+59.0%) |
| Dec 2020 | $100.13M(+138.3%) | $100.13M |
| Dec 2019 | $42.02M | - |
FAQ
- What is PROCEPT BioRobotics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics annual cash & cash equivalents year-on-year change?
- What is PROCEPT BioRobotics quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for PROCEPT BioRobotics?
- What is PROCEPT BioRobotics quarterly cash & cash equivalents year-on-year change?
What is PROCEPT BioRobotics annual cash & cash equivalents?
The current annual cash & cash equivalents of PRCT is $333.73M
What is the all time high annual cash & cash equivalents for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high annual cash & cash equivalents is $333.73M
What is PROCEPT BioRobotics annual cash & cash equivalents year-on-year change?
Over the past year, PRCT annual cash & cash equivalents has changed by +$76.50M (+29.74%)
What is PROCEPT BioRobotics quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of PRCT is $316.21M
What is the all time high quarterly cash & cash equivalents for PROCEPT BioRobotics?
PROCEPT BioRobotics all-time high quarterly cash & cash equivalents is $333.73M
What is PROCEPT BioRobotics quarterly cash & cash equivalents year-on-year change?
Over the past year, PRCT quarterly cash & cash equivalents has changed by +$90.63M (+40.18%)